Assembly Biosciences: UBS cuts target price to $48 from $52
ASMB•UBS cut its target price for Assembly Biosciences to $48 from $52.
Related News
Aehr jumps after reporting record quarterly revenue
AEHR•
Deals of the day: mergers and acquisitions
CVI•
Nasdaq trade halt: volatility trading pause at 9:46 a.m.
ABTS•
Quantum computing growth hinges on compute-per-watt, not qubit count, ETF Partners says
QQQ•
L3Harris receives $36 million order for US Army satellite communications terminals
LHX•